← FDA DRUG APPROVALS

FDA NDA · NDA004054

SULFADIAZINE

Sponsor: LEDERLE

APPLICATION
NDA004054
TYPE
NDA
ORIGINAL APPROVAL
1941-08-11
LATEST ACTION
1985-01-14
ROUTE
ORAL, INJECTION
DOSAGE FORM
TABLET, INJECTABLE
MARKETING STATUS
Discontinued

Products

SULFADIAZINEDiscontinued
SULFADIAZINE 500MG · TABLET · ORAL
SULFADIAZINE SODIUMDiscontinued
SULFADIAZINE SODIUM 250MG/ML · INJECTABLE · INJECTION

Approval history

1985-01-14Manufacturing (CMC) · Supplement 8AP
1980-01-17Manufacturing (CMC) · Supplement 7AP
1978-06-13Manufacturing (CMC) · Supplement 6AP
1978-01-23Manufacturing (CMC) · Supplement 5AP
1977-04-20Supplement · Supplement 1AP
1941-08-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →